申请人:Arbutus Biopharma Corporation
公开号:US20180104342A1
公开(公告)日:2018-04-19
Disclosed herein are lipid compositions comprising a cationic lipid of formula (I), a neutral lipid, a sterol and a PEG or PEG-modified lipid, wherein formula (I) is
Also disclosed are methods of producing the cationic lipid of formula (I).